On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayDec 27, 2017 12:24 pm

Medical Cannabis Payment Solutions (REFG) Prepares Seamless Transition for Payment Processing to Support Card Participation in Marijuana Industry

If Visa and MasterCard (or others) choose to participate in the marijuana industry in the future, REFG plans to offer quick, full spectrum payment processing REFG’s StateSourced payment gateway is Financial Crimes Enforcement Network (FinCEN) compliant Medical marijuana sales will grow to $13.3 billion by 2020, and adult recreational marijuana sales are expected to reach $11.2 billion by 2020, according to Forbes Medical Cannabis Payment Solutions (OTC: REFG) is ready for the future with a seamless transition in the event that Visa or MasterCard (or others) choose to participate in the marijuana industry. In the event of a transition, full…

Continue Reading

TuesdayDec 26, 2017 2:38 pm

NeutriSci International, Inc. (OTCQB: NRXCF) (TSX.V: NU) (FRA: IN9) Completes Private Placement, Will Use Proceeds for Neuenergy® Marketing

Neuenergy is a chewable and revolutionary energy tablet powered by blueberries and anti-oxidants with no sugar or calories NeutriSci International names Glen Rehman as new CEO Company sees new opportunities for its product in the cannabinoid field, as well as new strategic partnerships NeutriSci International, Inc. (OTCQB: NRXCF) (TSX.V: NU) (FRANKFURT: IN9) recently announced that it has raised $499,999.95 in a non-brokered private placement (http://nnw.fm/Eum9x), with the proceeds to be used for marketing and advertising of Neuenergy®, its branded blueberry-powered energy chewable tablet (http://nnw.fm/Hn6vN). Funds will also go to the company for general corporate purposes. In addition, the company announced…

Continue Reading

TuesdayDec 26, 2017 2:07 pm

Tapinator, Inc. (TAPM) Keeps Growing as Mobile Gaming Market Continues to Surge

Company has drawn more than 450 million players to its portfolio of 300+ mobile games, with player life time values (LTVs) exceeding the cost of player acquisition on certain titles TAPM schedules launch of three new full-featured titles in first two quarters of 2018 By 2020, mobile gaming market is expected to account for more than half of the total games market, which hit an estimated $108.9 billion this year Tapinator, Inc. (OTCQB: TAPM) has been successfully growing within the surging mobile games market through its introduction of both licensed and original IP across its portfolio of 300+ games, which…

Continue Reading

TuesdayDec 26, 2017 1:08 pm

India Globalization Capital, Inc. (NYSE: IGC) Targets February 2018 International Patent Filing for Eating Disorder Drug

Filing for IGC-506 anticipated to be completed in the U.S. in 2019, expanding the company’s patent portfolio; company is looking at pre-clinical trials for three of its combination drugs, possibly creating enhanced valuation IGC has pre-clinical trial scheduled in 2018 for IGC-AD1, a combination-therapy drug designed to treat Alzheimer’s IGC-506 is a combination therapy developed from cannabis extracts and other compounds that’s designed to treat multiple types of eating disorders in humans and animals India Globalization Capital, Inc. (NYSE American: IGC) (FRA: IGS1) anticipates a Patent Cooperation Treaty (“PCT”) filing application by February 28, 2018, for IGC-506, which is designed…

Continue Reading

TuesdayDec 26, 2017 12:33 pm

ChineseInvestors.com (CIIX) Successfully Incubates Spinoff

Multifaceted international company, first and only to offer hemp-infused skin care products in China Now set to spin off new subsidiaries Shareholders likely to benefit from value-add transaction In business for nearly two decades, ChineseInvestors.com (OTCQB: CIIX) began as a specialized investment services company providing real-time commentary, analysis and education-related services in the Chinese language. While building recurring revenues through its unique 100,000+ user base, CIIX maintained a long term vision for value-add opportunities. In 2016, the company identified one of the fastest growing markets in the world and entered the explosive new medical CBD market. Targeting the nearly two…

Continue Reading

TuesdayDec 26, 2017 11:13 am

Medical Cannabis Payment Solutions (REFG) Primed to Meet Needs of Legal Cannabis Consumers

Recreational and medical marijuana market in U.S. estimated to reach $37 billion by 2024 Need for payment processing solutions increases as cannabis continues march toward legalization Cryptocurrency presents a payment option, along with comprehensive card processing solutions Medical Cannabis Payment Solutions (OTC: REFG), the industry’s leading end-to-end payment processing solution for the legal marijuana industry, gives cannabis retailers and consumers different payment options besides bringing hard cash to the table. The company’s unique StateSourced proprietary system offers one of the first and only comprehensive card processing operations to serve state-sanctioned marijuana industries. StateSourced is not a prepaid or gift card,…

Continue Reading

FridayDec 22, 2017 12:30 pm

ChineseInvestors.com, Inc. (CIIX) to Spin Off CBD Biotechnology Co. and ChineseHempOil.com, Inc. to Focus on its Cryptocurrency Division and Core Financial Education Business

CIIX board has agreed, by the end of February 2018, to spin off its consumer products division in the U.S. and China, including its hemp oil assets and its new wholesale alcohol distribution division CIIX plans to register ChineseHempOil.com, Inc. as a separate publicly-traded company to be listed on the OTCQB Warren Wang, CEO of CIIX, said that the move will allow these businesses to grow in their respective markets ChineseInvestors.com, Inc. (OTCQB: CIIX) is spinning off its wholly-owned foreign entity, CBD Biotechnology Co., Ltd., and its wholly-owned subsidiary, ChineseHempOil.com, Inc., to allow itself to focus on its new cryptocurrency…

Continue Reading

FridayDec 22, 2017 10:26 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) and its Revolutionary Technology are Ready for the Cannabis Industry

Worldwide cannabis market expected to reach between $30 billion and $50 billion within four years Patent protected disruptive technology enables more efficient delivery and absorption of cannabinoids Groundbreaking delivery technology DehyraTECH™ positions Lexaria as potential M&A prospect Lexaria BioScience Corp. (CSE: LXX) (OTCQB: LXRP), a Canadian biosciences company that has developed delivery technologies to improve absorption of bioactive compounds, including cannabinoids, now has multiple patents pending in over 40 countries around the world. The company’s first patents, issued in the United States and Australia, relate to edible forms of cannabinoids or CBDs. Hot off a winning presentation at the 2017…

Continue Reading

FridayDec 22, 2017 9:40 am

SinglePoint, Inc. (SING) Cited by ‘The Greensheet Online Edition’ for Building a “Soup-To-Nuts” Platform for Operations Processing in the Cannabis Industry

Company plans to start processing cannabis payments from subsidiary SingleSeed Payments by January 2018 Goal is to build a fully integrated solution for cannabis businesses to help manage day-to-day operations from beginning to end SING plans more acquisitions in 2018, investing a significant amount of equity and cash into additional companies SinglePoint, Inc. (OTC: SING) has been cited by the The Greensheet Online Edition for building a “soup-to-nuts” platform for payment processing in the cryptocurrency and cannabis industries (http://nnw.fm/8A7bm). The goal, according to Wil Ralston, SING president, is to have a “fully integrated solution for businesses to manage their day-to-day…

Continue Reading

ThursdayDec 21, 2017 3:23 pm

Sage Therapeutics, Inc. (NASDAQ: SAGE) Builds Dreams of Depression Treatment Successes

Millions of people in North America report major depression concerns Sage Therapeutics drug trials return dramatic data Testing phase targets central nervous system biomolecule receptors Biopharmaceutical company Sage Therapeutics, Inc. (NASDAQ: SAGE) is reporting optimism over recent product testing in its efforts to reduce the debilitating effects of central nervous system disorders such as depression in its varied forms. Company CEO Jeff Jonas told a CNBC interviewer this month that he’s hopeful a pill now known as SAGE-217 may even become as prominently recognized as Prozac in the treatment of major depressive disorder (MDD), or clinical depression (http://nnw.fm/0PMwt). “What we…

Continue Reading

Contact us: 212.418.1217